tiprankstipranks
Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD
US Market
GLMD
Galmed Pharmaceuticals
RESEARCH TOOLSreports

Galmed Pharmaceuticals (GLMD) Income Statement

1,310 Followers

Galmed Pharmaceuticals Income Statement

Last quarter (Q4 2025), Galmed Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Galmed Pharmaceuticals's net income was $-4.82M. See Galmed Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -83.00K$ -31.00K$ -35.00K$ -42.00K
Operating Expenses
$ 8.51M$ 6.20M$ 7.46M$ 17.62M$ 32.84M
Depreciation and Amortization
$ 0.00$ 83.00K$ 31.00K$ 35.00K$ 42.00K
EBITDA
$ -8.51M$ -6.20M$ -7.46M$ -17.62M$ -32.84M
Operating Income
$ -8.51M$ -6.28M$ -7.49M$ -17.65M$ -32.88M
Other Income/Expenses
$ -1.80M$ -1.24M$ 580.00K$ -215.00K$ 414.00K
Pretax Income
$ -10.31M$ -7.52M$ -6.91M$ -17.87M$ -32.47M
Net Income
$ -10.31M$ -7.52M$ -6.91M$ -17.87M$ -32.47M
Per Share Metrics
Basic EPS
$ -2.39$ -8.08$ -30.05$ -11.08$ -19.48
Diluted EPS
$ -2.39$ -8.08$ -29.95$ -11.08$ -19.48
Weighted Average Shares Outstanding
 4.31M 930.82K 230.00K 1.68M 1.64M
Weighted Average Shares Outstanding (Diluted)
 4.31M 930.82K 230.79K 1.68M 1.64M
Currency in USD

Galmed Pharmaceuticals Earnings and Revenue History